Identification of a Preneoplastic Gene Expression Profile in Tubal Epithelium of BRCA1 Mutation Carriers

Microinvasive carcinomas and high-grade intraepithelial neoplasms are commonly discovered within the fallopian tube of BRCA1 mutation carriers at the time of risk-reducing salpingo-oophorectomy, suggesting that many BRCA1-mutated ovarian carcinomas originate in tubal epithelium. We hypothesized tha...

Full description

Bibliographic Details
Main Authors:	Joshua Z. Press, Kaitlyn Wurz, Barbara M. Norquist, Ming K. Lee, Christopher Pennil, Rochelle Garcia, Piri Welcsh, Barbara A. Goff, Elizabeth M. Swisher
Format:	Article
Language:	English
Published:	Elsevier 2010-12-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S147655861080017X

Similar Items

Patterns and duration of primary and recurrent treatment in ovarian cancer patients with germline BRCA mutations
by: Soledad Jorge, et al.
Published: (2019-08-01)

Risk modelling in BRCA1 and BRCA2 mutation carriers
by: Mavaddat, Nasim
Published: (2012)

Cancer risks in BRCA1 and BRCA2 mutation carriers
by: Thompson, Deborah Jane
Published: (2002)

Management of the asymptomatic BRCA mutation carrier
by: Paige Teller, et al.
Published: (2010-11-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas
by: Walsh Tom, et al.
Published: (2009-07-01)

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review
by: O. Bougie, et al.
Published: (2011-01-01)

Prostate cancer and targeted screening in BRCA1 and BRCA2 Mutation carriers
by: Mitra, Anita
Published: (2009)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
by: Metcalfe Kelly A, et al.
Published: (2005-04-01)

Fallopian Metaplastic Papillary Tumour: An Atypical Transdifferentiation of the Tubal Epithelium?
by: Miguel Fdo. Salazar, et al.
Published: (2015-03-01)

Aromatase expression is increased in <it>BRCA1 </it>mutation carriers
by: Chand Ashwini L, et al.
Published: (2009-05-01)

The Identification of BRCA1 and BRCA2 Mutation Carriers Using Functional Genomic Assays
by: Michel, CLAIRE S.
Published: (2008)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020-04-01)

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
by: Jaworska K, et al.
Published: (2012-01-01)

Comparison of risk assessment models of BRCA1 and BRCA2 mutation carrier in patients with breast cancer
by: Rybchenko L.A., et al.
Published: (2013-12-01)

Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014-07-01)

Genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
by: Kuchenbaecker, Karoline Bernhardine Elisabeth Karla Ursula
Published: (2015)

Preneoplastic lesions of the lung
by: Yee Herman, et al.
Published: (2002-04-01)

Molecular biological subtypes of breast cancer in BRCA1 mutation carriers
by: N. I. Pospekhova, et al.
Published: (2021-01-01)

Survival in Norwegian BRCA1 mutation carriers with breast cancer
by: Hagen Anne, et al.
Published: (2009-04-01)

Selected aspects of genetic counselling for <it>BRCA1 </it>mutation carriers
by: Gronwald Jacek
Published: (2007-03-01)

Management of Breast Cancer in BRCA1/2 Mutation Carriers
by: R. A. Eeles, et al.
Published: (1999-01-01)

Male BRCA mutation carriers: clinical characteristics and cancer spectrum
by: Mohammed Ibrahim, et al.
Published: (2018-02-01)

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers
by: Randal L. Croshaw, et al.
Published: (2011-01-01)

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
by: Petra van der Groep, et al.
Published: (2013-01-01)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
by: Phillips KA, et al.
Published: (2012-04-01)

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
by: Lisa Krassuski, et al.
Published: (2019-08-01)

Rapid detection of carriers with <it>BRCA1 </it>and <it>BRCA2 </it>mutations using high resolution melting analysis
by: Fox Stephen B, et al.
Published: (2008-02-01)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
by: G. Cipollini, et al.
Published: (1999-01-01)

Biochemical changes in preneoplastic livers
by: Edwards, Jennifer Jane
Published: (1989)

Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
by: Daphne Gschwantler-Kaulich, et al.
Published: (2017-01-01)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
by: Byrski T, et al.
Published: (2012-04-01)

DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers
by: Suba Z
Published: (2015-05-01)

Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers
by: Chiara Tommasi, et al.
Published: (2021-09-01)

Implications of BRCA-loss phenotype in epithelial ovarian carcinoma
by: Press, Joshua Zephyr
Published: (2011)

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
by: Stawicka Małgorzata, et al.
Published: (2008-04-01)

Decision aids for female BRCA mutation carriers: a scoping review protocol
by: David Mockler, et al.
Published: (2021-07-01)

Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study
by: Allison H. West, et al.
Published: (2019-09-01)

Cloning and characterization of elongation factor G genes /
by: Welcsh, Piri Louise
Published: (1992)

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in <i>BRCA1/BRCA2</i> Mutation Carriers Versus Non-Carriers
by: Michal Vocka, et al.
Published: (2019-05-01)